Heterozygous α1-antitrypsin phenotypes in patients with end stage liver disease

American Journal of Gastroenterology

Volumn 92, Issue 4, 1997, Pages 602-607

  Eigenbrodt, Marsha L ^a   McCashland, Timothy M ^b   Dy, Robert M ^b   Clark, James ^c   Galati, Joseph ^c  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; HEPATITIS C; HETEROZYGOSITY; HUMAN; LIVER CANCER; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; ALPHA 1-ANTITRYPSIN; ANALYSIS OF VARIANCE; CHRONIC DISEASE; CONFIDENCE INTERVALS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HETEROZYGOTE; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; PREVALENCE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 0030999090     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Fagerhol MK, Cox DW. The Pi polymorphism: Genetic, biochemical, and clinical aspects of human alpha-1-antitrypsin. Adv Hum Genet 1981;11:1-62.
2. Blank CA, Brantly M. Clinical features and molecular characteristics of alpha-1-antitrypsin deficiency. Ann Allergy 1994;72:105-20.
3. Mowat AP. Alpha-1-antitrypsin deficiency (Pi ZZ): Features of liver involvement in childhood. Acta Paediatr Suppl 1994;393:13-7.
4. Perlmutter DH. The cellular basis for liver injury in alpha-1-antitrypsin deficiency. Hepatology 1991;13:172-85.
5. Fabbretti G, Sergi C, Consales G, et al. Genetic variants of alpha-1-antitrypsin (AAT). Liver 1992;12:296-301.
6. Cox DW. Alpha-1-antitrypsin deficiency. In: Scriver CR, Beaudet AL, Sly WS, eds. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill, 1995: 4125-58.
7. Eriksson S, Hagerstrand I. Cirrhosis and malignant hepatoma in alpha-1-antitrypsin deficiency. Acta Med Scand 1974;195:451-8.
8. Triger DR, Millward-Sadler GH, Czaykowski AA, et al. Alpha-1-antitrypsin deficiency and liver disease in adults. Q J Med 1976;178: 351-72.
9. Berg NO, Eriksson S. Liver disease in adults with alpha-1-antitrypsin deficiency. N Engl J Med 1972;287:1264-7.
10. Larsson C. Natural history and life expectancy in severe alpha-1-antitrypsin deficiency, Pi Z. Acta Med Scand 1978;204:345-51.
11. Carlson J, Eriksson S. Chronic "cryptogenic" liver disease and malignant hepatoma in intermediate alpha-1-antitrypsin deficiency identified by a Pi Z-specific monoclonal antibody. Scand J Gastroenterol 1985; 20:835-42.
12. Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha-1-antitrypsin deficiency. N Engl J Med 1986;314: 736-9.
13. Eriksson S. Alpha-1-antitrypsin deficiency and liver cirrhosis in adults: An analysis of 35 Swedish autopsied cases. Acta Med Scand 1987; 221:461-7.
14. Cox DW, Smyth S. Risk for liver disease in adults with alpha-1-antitrypsin deficiency. Am J Med 1983;74:221-7.
15. Eriksson S, Moestrup T, Hagerstrand I. Liver, lung and malignant disease in heterozygous (Pi MZ) alpha-1-antitrypsin deficiency. Acta Med Scand 1975;198:243-7.
16. Hodges JR, Millward-Sadler GH, Barbatis C, et al. Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N Engl J Med 1981;304:557-60.
17. Lieberman J. Heterozygous MZ alpha-1-antitrypsin deficiency in liver disease. N Engl J Med 1981;305:171-2 (letter).
18. Vecchio FM, Fabiano A, Orsini G, et al. Alpha-1-antitrypsin MZ phenotype and cryptogenic chronic liver disease in adults. Digestion 1983;27:100-4.
19. Hultcrantz R, Glaumann H, Lindberg G, et al. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol 1986;21:109-13.
20. Roberts EA, Cox DW, Medline A, et al. Occurrence of alpha-1-antitrypsin deficiency in 155 patients with alcoholic liver disease. J Clin Pathol 1984;82:424-7.
21. Deutsch J, Becker H, Aubock L. Histopathological features of liver disease in alpha-1-antitrypsin deficiency. Acta Paediatr Suppl 1994; 393:8-12.
22. Deam D, Byron K, Ratnaike S. Alpha-1-antitrypsin in liver disease. Ann Clin Biochem 1989;26:122-4.
23. Bell H, Schrumpf E, Fagerhol MK. Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic liver disease. Scand J Gastroenterol 1990;25:788-92.
24. Propst T, Propst A, Dietze O, et al. High prevalence of viral infection in adults with homozygous and heterozygous alpha-1-antitrypsin deficiency and chronic liver disease. Ann Intern Med 1992;117:641-5.
25. Fisher RL, Taylor L, Sherlock S. Alpha-1-antitrypsin deficiency in liver disease: The extent of the problem. Gastroenterology 1976;71: 646-51.
26. Eriksson S. Liver disease and intermediate alpha-1-antitrypsin deficiency. Acta Med Scand 1981;210:241-4.
27. Vogel W, Propst T, Propst A, et al. Causes of liver disease in an adult population with heterozygous and homozygous alpha-1-antitrypsin deficiency. Acta Paediatr Suppl 1994;393:24-6.
28. Propst T, Propst A, Dietze O, et al. Alpha-1-antitrypsin deficiency and liver disease. Dig Dis 1994;12:139-49.
29. Dykes DD, Miller SA, Polesky HF. Distribution of alpha-1-antitrypsin variants in a US white population. Hum Hered 1984;34:308-10.
30. Joseph JK, Hay JE, Charlton MR, et al. Heterozygous alpha-1-antitrypsin deficiency (A1ATD) and liver failure. Hepatology 1996;24: 201A (abstract).
31. Perlmutter DH. Clinical manifestations of alpha-1-antitrypsin deficiency. Pediatr Gastroenterol 1995(pt 2);24:27-43.
32. Lomas DA, Evans DL, Finch JT, et al. The mechanism of Z alpha-1-antitrypsin accumulation in the liver. Nature 1992;357:605-7.
33. Dubuisson J, Hsu HH, Cheung RC, et al. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol 1994; 68:6147-60.
34. Dubuisson J, Rice CM. Hepatitis C virus glycoprotein folding: Disulfide bond formation and association with calnexin. J Virol 1996;70: 778-86.
35. Teckman JH, Qu D, Perlmutter DH. Molecular pathogenesis of liver disease in alpha-1-antitrypsin deficiency. Hepatology 1996;24:1504-16.
36. Wu Y, Whitman I, Molmenti E, et al. A lag in intracellular degradation of mutant alpha-1-antitrypsin correlates with the liver disease phenotype in homozygous Pi ZZ alpha-1-antitrypsin deficiency. Proc Natl Acad Sci USA 1994;91:9014-8.
37. Lomas DA. Loop-sheet polymerization: The structural basis of Z alpha-1-antitrypsin accumulation in the liver. Clin Sci 1994;86:489-95.
38. Perlmutter DH. The SEC receptor: A possible link between neonatal hepatitis in alpha-1-antitrypsin deficiency and Alzheimer's disease. Pediatr Res 1994;36:271-7.
39. Massi G. Pathogenesis and pathology of liver disease associated with alpha-1-antitrypsin deficiency. Chest 1996;110:251S-5S.
40. Hall PM. Pathologic spectrum of alcoholic liver disease. In Hall P, ed. Alcoholic liver disease: Pathology and pathogenesis, 2nd ed. Boston: Little, Brown & Co, 1995: 41-68.
41. Schwarzenberg SJ, Sharp HL. Pathogenesis of alpha-1-antitrypsin deficiency-associated liver disease, 1990. J Pediatr Gastroenterol Nutr 1990;10:5-12.
42. Nemeth A. Pathogenesis of liver disease in alpha-1-antitrypsin deficiency. Acta Paediatr Suppl 1994;393:5-7.
43. Tanaka M, Shimoda T, Takaki K, et al. Hepatic fibrosis: The relation between proliferating bile ductules and alpha-1-antitrypsin. Acta Pathol Jpn 1980;30:695-703.
44. Truden JL, Boros DL. Detection of alpha-2-macroglobulin, alpha-1-protease inhibitor, and neutral protease-antiprotease complexes within liver granulomas of Schistosoma mansoni-infected mice. Am J Pathol 1988;130:281-8.
45. Ozeki T, Imanishi K, Ueda H, et al. Alpha-1-antitrypsin and hepatic fibrosis. Br J Exp Pathol 1989;70:143-52.
46. Pittschieler K. Heterozygotes and liver involvement. Acta Paediatr Suppl 1994;393:21-3.
47. Kueppers F, Dickson ER, Summerskill WHJ. Alpha-1-antitrypsin phenotypes in chronic active liver disease and primary liver cirrhosis. Mayo Clin Proc 1976;51:286-8.
48. Lohr HF, Schlaak JF, Dienes HP, et al. Liver cirrhosis associated with heterozygous alpha-1-antitrypsin deficiency type Pi MS and autoimmune features. Digestion 1995;56:41-5.
49. Hennekens CH, Buring JE. Analysis of epidemiologic studies: Evaluating the role of bias. In: Mayrent SH, ed. Epidemiology in Medicine. Boston: Little, Brown & Co, 1987: 272-86.
50. Kueppers F, Christopherson MJ. Alpha-1-antitrypsin: Further genetic heterogeneity revealed by isoelectric focusing. Am J Hum Genet 1978;30:359-65.
51. Sveger T. The natural history of liver disease in alpha-1-antitrypsin deficient children. Acta Paediatr Scand 1988;77:847-51.
52. Sveger T, Eriksson S. The liver in adolescents with alpha-1-antitrypsin deficiency. Hepatology 1995;22:514-17.